Eli Lilly and Company
Explore Eli Lilly and Company
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Eli Lilly and Company
Explore Eli Lilly and Company
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2022 Revenue
$28.5B
▲ 0.8% vs FY2021 ($28.3B)
Source: Annual report / company filing
Eli Lilly and Company reported $28.5B in revenue for fiscal year 2022. This represents a growth of 0.8% compared to the 2021 figure of $28.3B. In 2023, revenue increased to $34.1B.
Growth stalled to a slight 0.8 percent rise, reaching $28.5 billion in 2022 as the newly approved Mounjaro had only launched midway through the year.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $65.2B | — | +44.8% |
| FY2024 | $45.0B | $10.6B | +31.9% |
| FY2023 | $34.1B | — | +19.6% |
| FY2022 | $28.5B | — | +0.8% |
| FY2021 | $28.3B | — | +15.5% |
| FY2020 | $24.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.